Sánchez-Navarro MR, Núñez-Martínez ME, Álvarez-Sánchez P, Moreno-López LC, Gómez-Morales E

Language: Spanish
References: 8
Page: 51-53
PDF size: 47.38 Kb.

Text Extraction

No abstract

REFERENCES

1. Schonewille H, van de Watering L, Loomans D, Brand A. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion 2006;46:250-256.

2. Aristizábal-Aristizábal JM, Domingo-Torres J. Transfusiones en pacientes con pruebas de compatibilidad positivas y en aquellos con anemia hemolítica autoinmune. Iatreia 2007;20:379-387.

3. Schonewille H, Haak HL, van Zijl AM. Alloimmunization after blood transfusion on patients with hematologic and oncologic diseases. Transfusion 1999;39:763-771.

4. Giblett ER. A critique of the theoretical hazard of inter vs. intra-racial transfusion. Transfusion 1961;1:223-228.

5. Tahhan HR, Holbrook CT, Braddy LR. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994;34:562-569.

6. Blumberg N, Ross K, Ávila E. Should chronic transfusions be matched for antigens other than ABO and Rh (D)? Vox Sanguinis 1984;47:205-208.

7. Dutcher JP, Schiffer CA, Aisner J. Long-term follow-up of patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized. Blood 1981;58:1007-1011.

8. Schonewille H, Haak HL, van Zijl AM. RBC antibody persistence. Transfusion 2000;40:1127-1131.